|
시장보고서
상품코드
2102320
SaMD(Software as a Medical Device) 시장 규모, 점유율, 성장 분석 : 용도별, 도입 형태별, 플랫폼별, 기술별, 적응증별, 최종사용자별, 지역별 - 업계 예측(2026-2033년)Software as a Medical Device Samd Market Size, Share, and Growth Analysis, By Application, By Deployment Mode, By Platform, By Technology, By Indication, By End User, By Region - Industry Forecast 2026-2033 |
||||||
세계의 SaMD(Software as a Medical Device) 시장 규모는 2024년에 107억 5,000만 달러로 평가되었으며, 2025년 131억 3,000만 달러에서 2033년까지 649억 4,000만 달러로 확대될 전망이며, 예측 기간(2026-2033년) 동안 CAGR 22.12%로 성장할 것으로 전망됩니다.
SaMD(Software as a Medical Device)의 시장 환경은 환자의 예후와 소프트웨어의 기능 강화 및 수익원을 연결하는 데이터 통합의 발전에 힘입어 급속히 진화하고 있습니다. 전자건강기록(EHR)과 원격 모니터링의 융합을 통해 기계 학습 모델을 활용한 위험 계층화가 가능해져, 적시에 치료법을 변경할 수 있게 되었습니다. 이 기술은 심부전으로 인한 재입원 비율을 현저히 감소시키는 등 큰 임상적 이점을 가져오고 있으며, 보험사의 SaMD 투자를 유도하고 있습니다. 벤처 캐피털의 유입은 확장성이 뛰어난 혁신적인 제품 개발을 촉진하여 시장 성장을 더욱 뒷받침하고 있습니다. 이러한 동향은 신생 기업의 부상과 의료기기 제조업체 및 클라우드 네이티브 기업 간의 전략적 제휴로 특징지어지며, 진단 및 폐쇄 루프 치료 솔루션에 이르는 적용 범위를 확대함으로써 SaMD 부문이 지닌 역동적인 가능성을 부각시키고 있습니다.
세계 SaMD(Software as a Medical Device) 시장의 성장 촉진요인
세계 SaMD(Software as a Medical Device) 시장은 규제 당국의 투명성 강화에 힘입어 성장하고 있습니다. 이를 통해 개발자들의 승인 절차가 원활해지고 있습니다. 이러한 투명성 향상으로 제조업체는 설계 및 검증 작업을 초기 단계부터 확립된 기준에 맞출 수 있게 되어, 결과적으로 시장 출시 기간을 단축할 수 있습니다. 개발자들이 투자에 대한 확신을 갖게 됨에 따라, SaMD 혁신에 주력하는 기업이 현저히 증가하고 있습니다. 이러한 활기찬 생태계는 이해관계자 간의 협력을 촉진하고, 제품 품질 향상과 시장 진입 가속화로 이어지는 선순환을 만들어내며, 궁극적으로 개발자와 최종사용자 모두에게 이익을 가져다줍니다.
세계 SaMD(Software as a Medical Device) 시장의 제약요인
세계 SaMD(Software as a Medical Device) 시장은 다양한 관할권에서 시행되는 엄격한 데이터 개인정보 보호 규제의 과제에 직면해 있습니다. 벤더는 견고한 암호화 기법의 도입, 효과적인 동의 관리 시스템 구축, 그리고 종합적인 감사 관행의 유지가 요구됩니다. 이러한 규정 준수 요건은 특히 전담 규정 준수 팀을 보유하지 않은 중소기업의 경우, 개발 기간의 장기화나 운영 비용의 증가로 이어질 가능성이 있습니다. 또한, 환자 데이터 보호에 대한 중요성이 커짐에 따라 데이터 분석 활동이 저해되고, 제품 개선을 위해 실제 임상 증거를 활용할 기회가 제한될 수 있습니다. 그 결과, 기업들은 시장 진입을 지연시키거나 혁신을 축소할 가능성이 있으며, 이는 SaMD 시장 전체의 성장을 저해할 우려가 있습니다.
세계 SaMD(Software as a Medical Device) 시장 동향
세계 SaMD(Software as a Medical Device) 시장에서는 AI를 활용한 진단 기능을 임상 워크플로우에 통합하는 뚜렷한 추세가 나타나고 있습니다. 이러한 진보를 통해 실시간 영상 분석 및 패턴 인식이 가능해지며, 외부 IT 시스템에 대한 의존도를 최소화하면서 임상의의 의사결정 과정을 강화합니다. SaMD가 진료 현장에서 중요한 자원이 됨에 따라 알고리즘의 투명성과 지속적인 학습에 대한 관심이 높아지고 있으며, 의료기기 개발자와 의료기관 간의 공동 검증 활동이 진행되고 있습니다. 이러한 변화는 규제 준수를 보장하고, AI 애플리케이션에 대한 신뢰를 조성하며, 다양한 의료 전문 분야에서 보다 광범위한 도입을 촉진하고, 궁극적으로 환자 치료의 혁신을 가져오는 것을 목표로 하고 있습니다.
자주 묻는 질문
목차
소개
조사 방법
주요 요약
시장 역학과 전망
주요 시장 인사이트
세계의 SaMD(Software as a Medical Device) 시장 규모 : 용도별
세계의 SaMD(Software as a Medical Device) 시장 규모 : 전개 방식별
세계의 SaMD(Software as a Medical Device) 시장 규모 : 플랫폼별
세계의 SaMD(Software as a Medical Device) 시장 규모 : 기술별
세계의 SaMD(Software as a Medical Device) 시장 규모 : 적응증별
세계의 SaMD(Software as a Medical Device) 시장 규모 : 최종사용자별
세계의 SaMD(Software as a Medical Device) 시장 규모 : 지역별
경쟁 정보
주요 기업 개요
결론과 제안
KSM 26.08.04Global Software As A Medical Device Samd Market size was valued at USD 10.75 Billion in 2024 and is poised to grow from USD 13.13 Billion in 2025 to USD 64.94 Billion by 2033, growing at a CAGR of 22.12% during the forecast period (2026-2033).
The landscape of Software as a Medical Device (SaMD) is rapidly evolving, driven by advancements in data integration that connect patient outcomes with software enhancements and revenue streams. The fusion of electronic health records and remote monitoring allows machine-learning models to deliver risk stratification, enabling timely therapeutic modifications. This technology demonstrates significant clinical benefits, such as reducing heart failure rehospitalizations by a notable percentage, attracting payer investment in SaMD. The influx of venture capital fosters scalable, innovative products, further stimulating market growth. This trend is marked by emerging players and strategic collaborations between device manufacturers and cloud-native firms, broadening applications across diagnostics and closed-loop treatment solutions, underscoring the dynamic potential within the SaMD sector.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Software As A Medical Device Samd market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Software As A Medical Device Samd Market Segments Analysis
Global software as a medical device SAMD market is segmented by application, deployment mode, platform, technology, indication, end user and region. Based on application, the market is segmented into diagnostics, disease monitoring, clinical decision support (CDS), treatment planning & management, medication management and preventive care & wellness. Based on deployment mode, the market is segmented into cloud-based, on-premises and hybrid. Based on platform, the market is segmented into web-based, mobile-based and desktop-based. Based on technology, the market is segmented into artificial intelligence (AI)/machine learning (ML)-based, rule-based software and conventional analytics software. Based on indication, the market is segmented into cardiovascular disorders, diabetes, oncology, neurology, respiratory disorders, mental health, musculoskeletal disorders and others. Based on end user, the market is segmented into hospitals & health systems, clinics & ambulatory care centers, diagnostic centers, home healthcare settings and patients/consumers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Software As A Medical Device Samd Market
The Global Software as a Medical Device (SaMD) market is driven by the enhanced clarity provided by regulatory agencies, which enables smoother approval processes for developers. This increased transparency allows manufacturers to align their design and validation efforts with established standards from the outset, consequently abbreviating the time to market. As developers gain confidence in their investments, there is a notable rise in companies focusing on SaMD innovation. This thriving ecosystem fosters collaboration among stakeholders, creating a positive feedback loop that enhances product quality and accelerates market entry, ultimately benefiting both developers and end users.
Restraints in the Global Software As A Medical Device Samd Market
The Global Software as a Medical Device (SaMD) market faces challenges from stringent data privacy regulations across various jurisdictions. Vendors are required to implement robust encryption methods, establish effective consent management systems, and maintain comprehensive auditing practices. These compliance demands can extend development timelines and elevate operational expenses, particularly for small and medium-sized enterprises lacking dedicated compliance teams. Furthermore, a heightened emphasis on safeguarding patient data can hinder data analytics initiatives, limiting opportunities to utilize real-world evidence for enhancing products. Consequently, companies may delay market entry or scale back on innovation, which can impede the overall growth of the SaMD market.
Market Trends of the Global Software As A Medical Device Samd Market
The Global Software As A Medical Device (SaMD) market is experiencing a significant trend towards the integration of AI-driven diagnostic capabilities into clinical workflows. This advancement enables real-time image analysis and pattern recognition, enhancing decision-making processes for clinicians while minimizing dependence on external IT systems. As SaMD becomes a critical point-of-care resource, the focus on algorithm transparency and continuous learning is intensifying, leading to collaborative validation efforts among device developers and healthcare institutions. This shift aims to ensure regulatory compliance, foster trust in AI applications, and promote broader adoption across diverse medical specialties, ultimately transforming patient care.
Table of Contents
Introduction
- Objectives of the Study
- Market Definition & Scope
Research Methodology
- Research Process
- Secondary & Primary Data Methods
- Market Size Estimation Methods
Executive Summary
- Global Market Outlook
- Key Market Highlights
- Segmental Overview
- Competition Overview
Market Dynamics & Outlook
- Macro-Economic Indicators
- Drivers & Opportunities
- Restraints & Challenges
- Supply Side Trends
- Demand Side Trends
- Porters Analysis & Impact
- Competitive Rivalry
- Threat of Substitute
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Key Market Insights
- Key Success Factors
- Market Impacting Factors
- Top Investment Pockets
- Ecosystem Mapping
- Market Attractiveness Index 2025
- PESTEL Analysis
- Regulatory Landscape
Global Software as a Medical Device Samd Market Size by Application & CAGR (2026-2033)
- Market Overview
- Diagnostics
- Disease Monitoring
- Clinical Decision Support (CDS)
- Treatment Planning & Management
- Medication Management
- Preventive Care & Wellness
Global Software as a Medical Device Samd Market Size by Deployment Mode & CAGR (2026-2033)
- Market Overview
- Cloud-Based
- On-Premises
- Hybrid
Global Software as a Medical Device Samd Market Size by Platform & CAGR (2026-2033)
- Market Overview
- Web-Based
- Mobile-Based
- Desktop-Based
Global Software as a Medical Device Samd Market Size by Technology & CAGR (2026-2033)
- Market Overview
- Artificial Intelligence (AI)/Machine Learning (ML)-Based
- Rule-Based Software
- Conventional Analytics Software
Global Software as a Medical Device Samd Market Size by Indication & CAGR (2026-2033)
- Market Overview
- Cardiovascular Disorders
- Diabetes
- Oncology
- Neurology
- Respiratory Disorders
- Mental Health
- Musculoskeletal Disorders
- Others
Global Software as a Medical Device Samd Market Size by End User & CAGR (2026-2033)
- Market Overview
- Hospitals & Health Systems
- Clinics & Ambulatory Care Centers
- Diagnostic Centers
- Home Healthcare Settings
- Patients/Consumers
Global Software as a Medical Device Samd Market Size & CAGR (2026-2033)
- North America (Application, Deployment Mode, Platform, Technology, Indication, End User)
- US
- Canada
- Europe (Application, Deployment Mode, Platform, Technology, Indication, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
- Asia Pacific (Application, Deployment Mode, Platform, Technology, Indication, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America (Application, Deployment Mode, Platform, Technology, Indication, End User)
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa (Application, Deployment Mode, Platform, Technology, Indication, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa
Competitive Intelligence
- Top 5 Player Comparison
- Market Positioning of Key Players, 2025
- Strategies Adopted by Key Market Players
- Recent Developments in the Market
- Company Market Share Analysis, 2025
- Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)
Key Company Profiles
- GE HealthCare Technologies Inc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Siemens Healthineers AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Koninklijke Philips NV
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Fujifilm Holdings Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Canon Medical Systems Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Volpara Health Technologies Limited
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Brainlab AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- iCAD Inc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- MaxQ AI Ltd
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Viz ai Inc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- HeartFlow Inc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- IDx Technologies Inc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Pear Therapeutics Inc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Akili Inc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Click Therapeutics Inc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- GlobalLogic
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- ICON plc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Medtronic plc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- ResMed Inc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Propeller Health
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
